Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Elkolaly (Tanta, Egypt), D. Ali (Tanta, Egypt). Galectn-3 : marker of airway inflammation in bronchial asthma. 954

Member's Comments

No comment yet.

Related content which might interest you: Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Increased airway closure is a determinant of airway hyperresponsiveness Source: Eur Respir J 2008; 32: 1563-1569 Year: 2008 Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Role of airway responsivenes in asthma monitoring: new horizons Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006 Small airways involvement is associated with bronchial hyperresponsiveness in asthma Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012 Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Effect of bronchial neutrophilia on airway remodeling in asthma Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 ADAM33 SNPs are associated with airway hyperresponsiveness and airway inflammation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005 The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Upper and lower airway inflammation and bronchial hyperresponsiveness in allergic rhinitis children with or without asthma Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness in children Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Bronchial hyperreactivity and airway inflammatory markers in nonasthmatic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003